Health Condition 1: J301- Allergic rhinitis due to pollen
Conditions
Interventions
Intervention1: Individualized homeopathic
medicines in centesimal potencies plus general management(Nasal irrigation, steam inhalation and proper diet): Intervention is planned as administering indica
dosage and repetition depending upon the individual requirement of the cases. All
medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm.
Duration of therapy: 4 weeks.
Co
Sponsors
DEPARTMENT OF SCIENCE & TECHNOLOGY AND BIOTECHNOLOGY VIGYAN CHETANA BHAVAN GOVERNMENT OF WEST BENGAL
Deben Mahata Government Medical College and Hospital Purulia
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient suffering from Allergic rhinitis (AR) for at least 1 year. Confirmative diagnosis of AR by medical history, symptoms, skin prick tests (SPTs) or other biochemical parameters. 2. Subject must be symptomatic at screening and willing to maintain same environment throughout the study. 3. Patients of both sexes; age 18-65 years. 4. Ability to read and write English or Bengali 5. Ability and willing to comply with study procedures.
Exclusion criteria
Exclusion criteria: 1. Having complications of nasal disease, or vasomotor rhinitis, rhinitis with eosinophilia, or drug rhinitis 2. Having complications of bacterial/viral infection of upper respiratory tract 3. Having significant systemic disease or any organ failure. 4. Subject suffering from any life threatening/Psychiatric/ illnesses or Immuno-compromised state or other significant disease conditions. 5. Pregnant or lactating woman 6. Substance abuse or dependence 7. Patients planning to travel outside the region 8. Patients who participated in another study within 4 months before screening 9. Patients taking drugs for other illness 10. Patients who have taken any homoeopathic medicines in last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Nasal Symptom Score (TNSS)Timepoint: Baseline, 1st week, 2nd week, 3rd week and 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)Timepoint: Baseline, 1st week, 2nd week, 3rd week and 4th week;IgE estimationTimepoint: Baseline and end point of study | — |
Countries
India
Contacts
Public ContactDr Soumyabrata Dogra
SHD SADAR at Deben Mahata Govt Medical College and Hospital
Outcome results
None listed